Natural History of Herpes Zoster in the Placebo Groups of Three Randomized Phase III Clinical Trials
CONCLUSION: The incidence and burden of HZ is high in immunocompetent adults aged ≥ 50 YOA and even more so in HSCT recipients aged ≥ 18 YOA.PMID:36322332 | DOI:10.1007/s40121-022-00689-7
Source: Herpes - Category: Infectious Diseases Authors: Desmond Curran Sean Matthews C éline Boutry Nicolas Lecrenier Anthony L Cunningham Kenneth Schmader Source Type: research
More News: Clinical Trials | Eyes | Herpes | Infectious Diseases | Pain | Shingles (Herpes Zoster) Vaccine | Stem Cell Therapy | Stem Cells | Study | Transplants | Vaccines | Varicella-Zoster Virus Vaccine